Matching-adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed-duration venetoclax and ibrutinib in patients with treatment-naive chronic lymphocytic leukaemia.
Loading...
LTHT Author
LTHT Department
Contributor Profession (Non Medical)
Publication Date
Item Type
Journal Article
Language
Subject
Subject Headings
Journal Title
Journal ISSN
Volume Title
Abstract
Journal
British Journal of Haematology